1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Kamada-AAT for Inhalation, 80mg: new trials by email Literature Review of Kamada-AAT for Inhalation, 80mg trials Research Report on Kamada-AAT for Inhalation, 80mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II, Safety and Efficacy Study of Kamada-alpha-1-antitrypsin (AAT) for Inhalation" Kamada-AAT for Inhalation, 80mg, Placebo, Kamada-AAT for Inhalation, 160mg - Alpha-1 Antitrypsin Deficiency | Phase 2 | Completed | Kamada, Ltd. | 36 | 2014-04-01 | 2020-01-18 |
alpha 1-Antitrypsin Deficiency (1)
Kamada, Ltd. (1)
United States (1)